Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Change in Account Payables of -$4.1 million in Q4 2025, down 120.66% quarter-over-quarter from $19.8 million in Q3 2025, and up 63.68% on a YoY basis from -$2.5 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$4.1 million for Q4 2025.
- In Q4 2025, Change in Account Payables rose 63.68% year-over-year to -$4.1 million; the TTM figure through Dec 2025 stood at $17.9 million (up 190.12% YoY), while the FY2025 annual figure was -$19.4 million, up 22.27% from the prior year.
- Change in Account Payables was -$4.1 million for Q4 2025 at Prestige Consumer Healthcare, down from $19.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $19.8 million in Q3 2025 to a low of -$15.6 million in Q2 2021.
- Historically, Change in Account Payables has averaged $446700.0 across 5 years, with a median of -$783500.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables tumbled 766.38% in 2023, then soared 366.33% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $2.2 million in 2021, then soared by 258.65% to $7.9 million in 2022, then sank by 165.31% to -$5.1 million in 2023, then tumbled by 118.8% to -$11.3 million in 2024, then surged by 63.68% to -$4.1 million in 2025.
- The last three Change in Account Payables figures came in at -$4.1 million (Q4 2025), $19.8 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | -4.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.09 Mn |
| Dec 31, 2025 | -4.09 Mn |
| Sep 30, 2025 | 19.79 Mn |
| Sep 30, 2025 | 19.79 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | -560,000.00 |
| Mar 31, 2025 | -560,000.00 |
| Dec 31, 2024 | -11.26 Mn |
| Dec 31, 2024 | -11.26 Mn |
| Sep 30, 2024 | -8.19 Mn |
| Sep 30, 2024 | -8.19 Mn |
| Jun 30, 2024 | 591,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | -1.01 Mn |
| Mar 31, 2024 | -1.01 Mn |
| Dec 31, 2023 | -5.14 Mn |
| Dec 31, 2023 | -5.14 Mn |
| Sep 30, 2023 | -13.22 Mn |
| Sep 30, 2023 | -13.22 Mn |